Your browser doesn't support javascript.
loading
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget.
Núñez F, Paulina; Quera, Rodrigo; Rubin, David T.
Afiliação
  • Núñez F P; Universidad de los Andes, Digestive Disease Center, Inflammatory Bowel Disease Program, Clinica, Santiago 7620157, RM, Chile.
  • Quera R; Universidad de los Andes, Digestive Disease Center, Inflammatory Bowel Disease Program, Clinica, Santiago 7620157, RM, Chile.
  • Rubin DT; Medicine Inflammatory Bowel Disease Center, University of Chicago, Chicago, IL 60637, United States. drubin@medicine.bsd.uchicago.edu.
World J Gastrointest Endosc ; 14(2): 85-95, 2022 Feb 16.
Article em En | MEDLINE | ID: mdl-35316980
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic immune-mediated inflammatory disease that primarily affects the gastrointestinal tract and is characterized by periods of activity and remission. The inflammatory activity of the disease involving the colon and rectum increases the risk of colorectal cancer (CRC) over the years. Although prevention strategies are evolving, regular surveillance for early detection of neoplasia as a secondary prevention strategy is paramount in the care of IBD patients. In this review article, we discuss the current evidence of the risks of developing CRC and evaluate the best available strategies for screening and surveillance, as well as future opportunities for cancer prevention.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article